Charm Therapeutics
PrivateLast Round
Series B
Sep 2, 2025
Total Funding Raised
$130M
Company Overview
Charm Therapeutics is a biotechnology company that utilizes a proprietary AI-driven drug discovery platform, DragonFold, to develop transformative medicines for patients with challenging diseases such as cancer.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Charm Therapeutics Comparables
Compare Charm Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genesis Therapeutics | 87% | |
| Iambic Therapeutics | 85% | |
| Peptone | 83% |
Charm Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 2, 2025 | ||||
| VC Round | Apr 14, 2023 | ||||
| Series A | Jun 9, 2022 |
Key People
Founding team and executive leadership
Charm Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Braavos Investment Advisers | Series A |
| New Enterprise Associates | Series B |
| Khosla Ventures | Series A, Series B |
| Grep VC | Series A |
| F-Prime Capital | Series B, Series A |
| OrbiMed | Series B, Series A |
| General Catalyst | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 8, 2025
Dr. Erkut Bahceci appointed as the new Chief Medical Officer.
- Sep 2, 2025
$80M round completed.
Charm Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Charm Therapeutics's valuation, stock price, and market status.
Is Charm Therapeutics a public or private company?
Charm Therapeutics is a private company.
What is the current stock price of Charm Therapeutics?
Charm Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Charm Therapeutics worth (valuation)?
Valuation information for Charm Therapeutics is not publicly available.
Can I buy Charm Therapeutics stock?
Charm Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Charm Therapeutics's last funding round?
Charm Therapeutics's most recent funding round was Series B on September 2, 2025.
Who are the main investors in Charm Therapeutics?
Key investors in Charm Therapeutics include New Enterprise Associates (NEA), F-Prime Capital, OrbiMed, NVentures, SR One.
Will Charm Therapeutics IPO soon?
No public IPO plans have been announced for Charm Therapeutics.
How can I track Charm Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Charm Therapeutics's secondary market activity and sign up for updates.